Dr. Andrew Lyon has over 20 years of experience as a chemist, bioengineer, educator, and entrepreneur and currently serves as the Founding Dean of the Dale E. and Sarah Ann Fowler School of Engineering at Chapman University. Prior to his current role, he served as Dean of the Schmid College of Science and Technology at Chapman University from 2014-2018. Before arriving at Chapman, Dr. Lyon spent 16 years at the Georgia Institute of Technology as a member of the Chemistry & Biochemistry faculty and directing a research program aimed at creating new types of biomaterials for regenerative medicine applications. In addition to his role at Chapman, he is the co-founder and Chief Scientific Officer of Sanguina, Inc., SelSym Biotech, Inc., and Split Rock Therapeutics, LLC, three early-stage biotechnology companies. He is the recipient of the NSF CAREER, Beckman Young Investigator, Research Corporation Research Innovation, and Camille Dreyfus Teacher-Scholar Awards, an Alfred P. Sloan Fellowship, and the National Fresenius Award.